Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADA | P00813 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HBB | P68871 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL136037 | 0.88 | ADA (0.61) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL41684 | 0.88 | ADA (0.61) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL2028602 | 0.88 | ADA (0.61) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL5950184 | 0.88 | ADA (0.46) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL5064838 | 0.87 | ADA (0.60) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL772296 | 0.87 | ADA (0.63) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL8840658 | 0.87 | ADA (0.60) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL899393 | 0.86 | ADA (0.58) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL8000695 | 0.86 | ADA (0.58) | ADAALDH1A1TP53HTTBLM | |
| SCHEMBL3345754 | 0.86 | ADA (0.60) | ADAALDH1A1TP53HTTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2242 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4029522-B1 | METHOD FOR REDUCING IMMUNOGENICITY OF RNA | BioNTech SE (DE) | 2025-08-13 | — | — | EP | claimed |
| WO-2025137275-A1 | NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME | MODERNATX, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| CN-119824011-A | MRNA medicine for treating acrylic acid blood disease and its application | 中国医学科学院北京协和医院 | 2025-04-15 | — | — | CN | claimed |
| EP-4426720-A1 | MODIFIED MRNA THERAPEUTICS | Shattuck Labs, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118425361-A | Purine nucleoside metabolic marker for distinguishing wild and cultivated four-big domestic fish and application | 中国水产科学研究院长江水产研究所 | 2024-08-02 | — | — | CN | claimed |
| WO-2024129779-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024031087-A2 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2023215498-A2 | COMPOSITIONS AND METHODS FOR CD28 ANTAGONISM | MODERNATX, INC. (US) | 2023-11-09 | — | — | WO | claimed |
| EP-2201118-B1 | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION | TRANA DISCOVERY (US) | 2012-04-18 | — | — | EP | claimed |
| EP-2427470-A1 | METHOD FOR THE SOLID PHASE-BASED PRODUCTION OF PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | Universität Hamburg (DE) | 2012-03-14 | — | — | EP | claimed |
| WO-2011113607-A1 | MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) | 2011-09-22 | — | — | WO | claimed |
| US-20110137023-A1 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | UNIVERSITAET HAMBURG (DE) | 2011-06-09 | — | — | US | claimed |
| EP-2321330-A1 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | Universität Hamburg (DE) | 2011-05-18 | — | — | EP | claimed |
| EP-2262820-A1 | METHOD FOR THE STEREOSELECTIVE SYNTHESIS OF PHOSPHORUS COMPOUNDS | Universität Hamburg (DE) | 2010-12-22 | — | — | EP | claimed |
| WO-2010127666-A1 | METHOD FOR THE SOLID PHASE-BASED PRODUCTION OF PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | UNIVERSITÄT HAMBURG (DE) | 2010-11-11 | — | — | WO | claimed |
| WO-2010015245-A1 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES | UNIVERSITÄT HAMBURG (DE) | 2010-02-11 | — | — | WO | claimed |
| WO-2009121347-A1 | METHOD FOR THE STEREOSELECTIVE SYNTHESIS OF PHOSPHORUS COMPOUNDS | UNIVERSITÄT HAMBURG (DE) | 2009-10-08 | — | — | WO | claimed |
| EP-1424064-B1 | Use of adenosin or an adenosin analog to smooth out fine lines | OREAL (FR) | 2007-06-06 | — | — | EP | claimed |